Prenatal Exposure to TCDD Triggers Significant Modulation of microRNA Expression Profile in the Thymus That Affects Consequent Gene Expression

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Singh, Narendra P ^a   Singh, Udai P ^a   Guan, Hongbing ^a   Nagarkatti, Prakash ^a   Nagarkatti, Mitzi ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450 1A1; DIOXIN; FAS ANTIGEN; FAS LIGAND; LET 7E; MICRORNA; MICRORNA 122; MICRORNA 181A; MICRORNA 182; MICRORNA 18B; MICRORNA 200A; MICRORNA 23A; MICRORNA 31; MICRORNA 98; PROTEIN BCL XL; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; APOPTOSIS; ARTICLE; CLINICAL PATHWAY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FETUS; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOTOXICITY; MICROARRAY ANALYSIS; MOUSE; NEOPLASM; NONHUMAN; PRENATAL EXPOSURE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYMOCYTE; THYMUS; THYMUS ATROPHY; UPREGULATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CLUSTER ANALYSIS; CYTOCHROME P-450 CYP1A1; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; MATERNAL EXPOSURE; MICE; MICRORNAS; NEOPLASMS; PREGNANCY; RECEPTORS, ARYL HYDROCARBON; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; THYMOCYTES; THYMUS GLAND;

EID: 84866386286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045054     Document Type: Article

References (100)

1. Krol J, Loedige I, Filipowicz W, (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610.
2. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
3. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
4. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468.
5. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, et al. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441: 537-541.
6. Tsuchiya Y, Nakajima M, Takagi S, Taniya T, Yokoi T, (2006) MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66: 9090-9098.
7. Fukushima T, Hamada Y, Yamada H, Horii I, (2007) Changes of micro-RNA expression in rat liver treated by acetaminophen or carbon tetrachloride-regulating role of micro-RNA for RNA expression. J Toxicol Sci 32: 401-409.
8. Pogribny IP, Tryndyak VP, Boyko A, Rodriguez-Juarez R, Beland FA, et al. (2007) Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat Res 619: 30-37.
9. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, et al. (2009) Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. Faseb J 23: 806-812.
10. Maccani MA, Avissar-Whiting M, Banister CE, McGonnigal B, Padbury JF, et al. (2010) Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics 5: 583-589.
11. Avissar-Whiting M, Veiga KR, Uhl KM, Maccani MA, Gagne LA, et al. (2010) Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol 29: 401-406.
12. Komagata S, Nakajima M, Takagi S, Mohri T, Taniya T, et al. (2009) Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b. Mol Pharmacol 76: 702-709.
13. Boverhof DR, Tam E, Harney AS, Crawford RB, Kaminski NE, et al. (2004) 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces suppressor of cytokine signaling 2 in murine B cells. Mol Pharmacol 66: 1662-1670.
14. Camacho IA, Nagarkatti M, Nagarkatti PS, (2004) Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on maternal immune response during pregnancy. Arch Toxicol 78: 290-300.
15. Dearstyne EA, Kerkvliet NI, (2002) Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced decrease in anti-CD3-activated CD4(+) T cells: the roles of apoptosis, Fas, and TNF. Toxicology 170: 139-151.
16. Dong W, Teraoka H, Kondo S, Hiraga T, (2001) 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin induces apoptosis in the dorsal midbrain of zebrafish embryos by activation of arylhydrocarbon receptor. Neurosci Lett 303: 169-172.
17. Esser C, (1994) Dioxins and the immune system: mechanisms of interference. A meeting report. Int Arch Allergy Immunol 104: 126-130.
18. Faith RE, Luster MI, (1979) Investigations on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on parameters of various immune functions. Ann N Y Acad Sci 320: 564-571.
19. Kamath AB, Nagarkatti PS, Nagarkatti M, (1998) Characterization of phenotypic alterations induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocytes in vivo and its effect on apoptosis. Toxicol Appl Pharmacol 150: 117-124.
20. Singh NP, Nagarkatti M, Nagarkatti P, (2008) Primary peripheral T cells become susceptible to 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in vitro upon activation and in the presence of dendritic cells. Mol Pharmacol 73: 1722-1735.
21. Barker DJ, Eriksson JG, Forsen T, Osmond C, (2002) Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31: 1235-1239.
22. Phillips DI, (2006) External influences on the fetus and their long-term consequences. Lupus 15: 794-800.
23. Mustafa A, Holladay SD, Goff M, Witonsky S, Kerr R, et al. (2009) Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters postnatal T cell phenotypes and T cell function and exacerbates autoimmune lupus in 24-week-old SNF1 mice. Birth Defects Res A Clin Mol Teratol 85: 828-836.
24. Marlowe JL, Puga A, (2005) Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J Cell Biochem 96: 1174-1184.
25. Gonzalez FJ, Fernandez-Salguero P, (1998) The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos 26: 1194-1198.
26. Mimura J, Fujii-Kuriyama Y, (2003) Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 1619: 263-268.
27. Schmidt JV, Bradfield CA, (1996) Ah receptor signaling pathways. Annu Rev Cell Dev Biol 12: 55-89.
28. Tijet N, Boutros PC, Moffat ID, Okey AB, Tuomisto J, et al. (2006) Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 69: 140-153.
29. Camacho IA, Nagarkatti M, Nagarkatti PS, (2004) Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 78: 96-106.
30. Singh NP, Singh US, Nagarkatti M, Nagarkatti PS, (2011) Resveratrol (3,5,4'-trihydroxystilbene) protects pregnant mother and fetus from the immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Nutr Food Res 55: 209-219.
31. Blaylock BL, Holladay SD, Comment CE, Heindel JJ, Luster MI, (1992) Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicol Appl Pharmacol 112: 207-213.
32. Camacho IA, Nagarkatti M, Nagarkatti PS, (2002) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells. Arch Toxicol 76: 570-580.
33. Camacho IA, Singh N, Hegde VL, Nagarkatti M, Nagarkatti PS, (2005) Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of fas ligand in thymic stromal cells and consequent apoptosis in T cells. J Immunol 175: 90-103.
34. Fisher MT, Nagarkatti M, Nagarkatti PS, (2005) 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery. Mol Pharmacol 67: 327-335.
35. Frazier DE Jr, Silverstone AE, Gasiewicz TA, (1994) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced thymic atrophy and lymphocyte stem cell alterations by mechanisms independent of the estrogen receptor. Biochem Pharmacol 47: 2039-2048.
36. Kamath AB, Camacho I, Nagarkatti PS, Nagarkatti M, (1999) Role of Fas-Fas ligand interactions in 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced immunotoxicity: increased resistance of thymocytes from Fas-deficient (lpr) and Fas ligand-defective (gld) mice to TCDD-induced toxicity. Toxicol Appl Pharmacol 160: 141-155.
37. Kamath AB, Xu H, Nagarkatti PS, Nagarkatti M, (1997) Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo. Toxicol Appl Pharmacol 142: 367-377.
38. Singh NP, Nagarkatti M, Nagarkatti PS, (2007) Role of dioxin response element and nuclear factor-kappaB motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression. Mol Pharmacol 71: 145-157.
39. Park SM, Gaur AB, Lengyel E, Peter ME, (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907.
40. Nakano H, Miyazawa T, Kinoshita K, Yamada Y, Yoshida T, (2010) T Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Int J Cancer 127: 1072-1080.
41. Arpiainen S, Raffalli-Mathieu F, Lang MA, Pelkonen O, Hakkola J, (2005) Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway. Mol Pharmacol 67: 1325-1333.
42. Bock KW, Kohle C, (2006) Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol 72: 393-404.
43. Denison MS, Heath-Pagliuso S, (1998) The Ah receptor: a regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull Environ Contam Toxicol 61: 557-568.
44. Durrin LK, Jones PB, Fisher JM, Galeazzi DR, Whitlock JP Jr, (1987) 2,3,7,8-Tetrachlorodibenzo-p-dioxin receptors regulate transcription of the cytochrome P1-450 gene. J Cell Biochem 35: 153-160.
45. Bertazzi PA, Zocchetti C, Pesatori AC, Guercilena S, Sanarico M, et al. (1989) Mortality in an area contaminated by TCDD following an industrial incident. Med Lav 80: 316-329.
46. Jenkins S, Rowell C, Wang J, Lamartiniere CA, (2007) Prenatal TCDD exposure predisposes for mammary cancer in rats. Reprod Toxicol 23: 391-396.
47. Leder A, Kuo A, Cardiff RD, Sinn E, Leder P, (1990) v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci U S A 87: 9178-9182.
48. Mustafa A, Holladay SD, Witonsky S, Zimmerman K, Reilly CM, et al. (2009) Gestational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin disrupts B-cell lymphopoiesis and exacerbates autoimmune disease in 24-week-old SNF1 mice. Toxicol Sci 112: 133-143.
49. Wyde ME, Braen AP, Hejtmancik M, Johnson JD, Toft JD, et al. (2004) Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice. Toxicol Sci 82: 34-45.
50. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
51. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.
52. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004.
53. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, et al. (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065.
54. Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, et al. (2008) MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem 283: 18158-18166.
55. Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, et al. (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 120: 1298-1309.
56. Mardin WA, Mees ST, (2009) MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma? Ann Surg Oncol 16: 3183-3189.
57. Sassen S, Miska EA, Caldas C, (2008) MicroRNA: implications for cancer. Virchows Arch 452: 1-10.
58. Holsapple MP, Morris DL, Wood SC, Snyder NK, (1991) 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: possible mechanisms. Annu Rev Pharmacol Toxicol 31: 73-100.
59. Kerkvliet NI, (2002) Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2: 277-291.
60. Kiyohara C, Nakanishi Y, Inutsuka S, Takayama K, Hara N, et al. (1998) The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics 8: 315-323.
61. Sulentic CE, Holsapple MP, Kaminski NE, (1998) Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol Pharmacol 53: 623-629.
62. Takemoto K, Nakajima M, Fujiki Y, Katoh M, Gonzalez FJ, et al. (2004) Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol 78: 309-315.
63. Moffat ID, Boutros PC, Celius T, Linden J, Pohjanvirta R, et al. (2007) microRNAs in adult rodent liver are refractory to dioxin treatment. Toxicol Sci 99: 470-487.
64. Yoshioka W, Higashiyama W, Tohyama C (2011) Involvement of microRNAs in dioxin-induced liver damage in the mouse. Toxicol Sci.
65. Halappanavar S, Wu D, Williams A, Kuo B, Godschalk RW, et al. (2011) Pulmonary gene and microRNA expression changes in mice exposed to benzo(a)pyrene by oral gavage. Toxicology 285: 133-141.
66. Dietert RR, Piepenbrink MS, (2008) The managed immune system: protecting the womb to delay the tomb. Hum Exp Toxicol 27: 129-134.
67. Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, et al. (2011) Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection. Am J Gastroenterol.
68. Bandi N, Vassella E, (2011) miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol Cancer 10: 55.
69. Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, et al. (2011) Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med 3: 279-290.
70. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, et al. (2010) Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 21: 438-447.
71. Ma L, Li N, He X, Zhang Q, (2011) miR-449b and miR-34c on inducing down-regulation of cell cycle-related proteins and cycle arrests in SKOV3-ipl cell, an ovarian cancer cell line]. Beijing Da Xue Xue Bao 43: 129-133.
72. Malik AI, Williams A, Lemieux CL, White PA, Yauk CL (2012) Hepatic mRNA, microRNA, and miR-34a-Target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation. Environ Mol Mutagen.
73. Nakamura Y, Inloes JB, Katagiri T, Kobayashi T, (2011) Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling. Mol Cell Biol 31: 3019-3028.
74. Qin X, Wang X, Wang Y, Tang Z, Cui Q, et al. (2010) MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proc Natl Acad Sci U S A 107: 3240-3244.
75. Taganov KD, Boldin MP, Chang KJ, Baltimore D, (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103: 12481-12486.
76. Zhang X, Yu H, Lou JR, Zheng J, Zhu H, et al. (2011) MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J Biol Chem 286: 1429-1435.
77. Zhang XJ, Ye H, Zeng CW, He B, Zhang H, et al. (2010) Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol 3: 46.
78. Nebert DW, Puga A, Vasiliou V, (1993) Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann N Y Acad Sci 685: 624-640.
79. Okey AB, Riddick DS, Harper PA, (1994) The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol Lett 70: 1-22.
80. Olnes MJ, Verma M, Kurl RN, (1994) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated gene expression in the immature rat thymus. Exp Clin Immunogenet 11: 102-109.
81. Tian Y, Ke S, Denison MS, Rabson AB, Gallo MA, (1999) Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 274: 510-515.
82. Uno S, Dalton TP, Sinclair PR, Gorman N, Wang B, et al. (2004) Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria. Toxicol Appl Pharmacol 196: 410-421.
83. Schickel R, Park SM, Murmann AE, Peter ME, (2010) miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol Cell 38: 908-915.
84. Viluksela M, Bager Y, Tuomisto JT, Scheu G, Unkila M, et al. (2000) Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains. Cancer Res 60: 6911-6920.
85. Robertus JL, Harms G, Blokzijl T, Booman M, de Jong D, et al. (2009) Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. Mod Pathol 22: 547-555.
86. Zhang J, Guo H, Qian G, Ge S, Ji H, et al. (2010) MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network. Mol Cancer 9: 211.
87. Fiore R, Khudayberdiev S, Christensen M, Siegel G, Flavell SW, et al. (2009) Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. Embo J 28: 697-710.
88. Khudayberdiev S, Fiore R, Schratt G, (2009) MicroRNA as modulators of neuronal responses. Commun Integr Biol 2: 411-413.
89. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, et al. (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76: 582-588.
90. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, et al. (2008) miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284.
91. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
92. Pan YZ, Gao W, Yu AM, (2009) MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37: 2112-2117.
93. Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, et al. (2009) Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol 16: 2339-2350.
94. Krutovskikh VA, Herceg Z, (2010) Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays 32: 894-904.
95. Gu W, An J, Ye P, Zhao KN, Antonsson A, (2011) Prediction of conserved microRNAs from skin and mucosal human papillomaviruses. Arch Virol 156: 1161-1171.
96. Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, et al. (2009) MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers 14: 529-538.
97. Noonan EJ, Place RF, Basak S, Pookot D, Li LC, (2010) miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget 1: 349-358.
98. Ostling P, Leivonen SK, Aakula A, Kohonen P, Makela R, et al. (2011) Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Cancer Res 71: 1956-1967.
99. Marcucci G, Mrozek K, Radmacher MD, Garzon R, Bloomfield CD, (2011) The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood 117: 1121-1129.
100. Singh NP, Hegde VL, Hofseth LJ, Nagarkatti M, Nagarkatti P, (2007) Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol 72: 1508-1521.